Who We Are

The New Jersey Life Sciences Vendors Alliance (NJLSVA) is a coalition of businesses, individuals and academia who provide goods and services to New Jersey’s life sciences companies.

The NJLSVA was founded to educate suppliers on trends in industry procurement and public policy that affects the life sciences industry.

Choose NJ’s RFP Watch

Choose New Jersey’s RFP Watch provides up-to-date information on business opportunities throughout the Garden State at a cost that is affordable for all companies – with a place of business in New Jersey – large and small.

To learn more click here

HINJ Responds to PolitiFact Story on NJ Pharma Job Losses

New Brunswick, NJ, February 28, 2013 — In a letter to the editor of The Star-Ledger, the HealthCare Institute of New Jersey (HINJ) on Monday responded to a PolitiFact story regarding job losses in the New Jersey pharmaceutical industry.

The PolitiFact article about pharmaceutical jobs in New Jersey that appeared in the February 24 edition of The Star-Ledger stated that “In December 2012 New Jersey had 28,100 pharma jobs.…”

However, HINJ pointed out that, according to its latest economic impact report, 19 of 30 HINJ member companies reported employing 51,619 people in 2010.  Furthermore, this number does not include employment at the hundreds of non-HINJ pharmaceutical, biotechnology and medical technology companies in the state. 

HINJ’s letter to the Ledger editor further noted that “employment figures are reported by our member companies and include all job functions, whereas the Bureau of Labor Statistics (BLS) separates job functions into distinct classifications, so you may need to look at more than one classification to get the full picture.”

“In fact, in its 2012 ‘Life Sciences Cluster Report,’ Jones Lang LaSalle, using BLS statistics, reported that the Northern/Central New Jersey and New York City area employed more than 106,000 people in the life sciences,” HINJ said.

The HINJ letter concluded, “Merger activity, changing business models and global economic forces have impacted the industry worldwide; New Jersey is no exception and has experienced its share of job losses.  In spite of these challenges, New Jersey remains a strong, global leader in the life sciences.”